Algomedix (United States)

Home - Algomedix TRP Therapeutics

Transient Receptor Potential (TRP) Therapeutics A New Approach to Pain Treatment Unlocking the TRP Therapeutic Potential Non-Opioid, Non-Addictive, Pain Therapeutics. Algomedix is developing novel Transient Receptor Potential (TRP) therapeutics to treat serious unmet medical needs including acute and chronic pain and kidney disease. Chronic pain affects up to 30 percent of the worldwide population. Opioid […]